Belvedere Trading
CDLX icon

Belvedere Trading’s Cardlytics CDLX Stock Holding History

Belvedere Trading’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.52K Buy
2,556
+1,795
+236% +$7.07K ﹤0.01% 973
2026
Q2 		$3.42K Buy
+761
New +$5.69K ﹤0.01% 999
2024
Q2 		– Sell
-1,105
Closed -$160K – 718
2024
Q1 		$160K Buy
+1,105
New +$93.3K ﹤0.01% 370
2023
Q3 		– Sell
-733
Closed -$46.3K – 692
2023
Q2 		$46.3K Buy
+733
New +$44.4K ﹤0.01% 558

Other funds holding CDLX

KPS Global Asset Management (UK)
KPS Global Asset Management (UK) London, United Kingdom $625M AUM 17% 1-Year Est. Return
Kingsbury Capital Investment Advisors
Kingsbury Capital Investment Advisors Wilmette, Illinois $106M AUM
EverSource Wealth Advisors
EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Belvedere Trading's CDLX Position: Q3 2026 in Review

Belvedere Trading increased its Cardlytics (CDLX) stake by 236% in Q3 2026, buying an estimated $7.07K and bringing the position to 2,556 shares worth $7.52K. The position accounts for ﹤0.01% of the portfolio, ranked #973.

Belvedere Trading first reported a position in CDLX in Q2 2023 and has held it in 4 quarters since. The position peaked at $160K in Q1 2024. 9 funds tracked by Wall St. Rank hold CDLX as of Q3 2026.

  • Belvedere Trading held 2,556 shares of Cardlytics worth $7.52K as of Q3 2026.
  • Belvedere Trading bought 1,795 Cardlytics shares in Q3 2026, an estimated $7.07K.
  • Cardlytics made up ﹤0.01% of Belvedere Trading's portfolio in Q3 2026, its #973 holding.
  • Belvedere Trading first reported a position in Cardlytics in Q2 2023 and has held it in 4 quarters since.
  • Belvedere Trading's Cardlytics position peaked at $160K in Q1 2024.
  • 9 funds tracked by Wall St. Rank held Cardlytics as of Q3 2026.

Based on Belvedere Trading's 13F filing for Q3 2026, filed 5 Nov 2026.